Journal of the American Medical Association · 1950 · 48 citations · 21 references
MedicineHematologyToxicologyBioavailabilityIron Metabolism DisordersTransfusion MedicineAnemiaIron Chelation TherapyIron DeficiencyIron Deficiency DisordersIron NutritionIron OxidesBlood PressureIntravenous Iron AdministrationIron Deficiency ManagementIron Deficiency TreatmentOral Iron ChelatorsParenteral Iron ChelationSystolic Blood Pressure
Saccharated iron oxide given intravenously has recently been used successfully by several groups of British investigators for the treatment of iron deficiency anemia.<sup>1</sup>The therapeutic response has been uniformly good; reactions have been both infrequent and mild. It is surprising that the preparation can be injected with relative safety since all other forms of iron administered parenterally have caused reactions so severe that their use had to be abandoned; these include ferrous citrate, iron citrate green, ferrous gluconate, ferrous ascorbate, colloidal ferric hydroxide and colloidal ferric oxide.<sup>2</sup>The toxic manifestations commonly observed with the last two compounds were nausea, vomiting, abdominal and lower back pain, lacrimation, nasal stuffiness, headache, flushing and swelling of the face, swelling and stiffness of the tongue, paresthesias, fever, rapid fall in systolic blood pressure, substernal pain and a sense of impending death. The earlier studies with these therapeutically unsatisfactory iron preparations, however, had
21
INTRAVENOUS ADMINISTRATION OF IRON
JosephA. Nissim · The Lancet · 1947 · 169 citations
EXOGENOUS HEMOCHROMATOSIS RESULTING FROM BLOOD TRANSFUSIONS
Steven O. Schwartz, Sunoll A. Blumenthal · Blood · 1948 · 84 citations · Full text